7th Annual Live Medical Crossfire®: Hematologic Malignancies
Coverage of the 7th Annual Live Medical Crossfire®: Hematologic Malignancies, focusing on CLL research
A panel discussed the optimal treatment for patients with acute myeloid leukemia, as well as maintenance approaches.
Options for treating ALL have improved in recent years, but questions about treatment approaches remain.
There is no optimal initial therapy for patients with chronic lymphocytic leukemia, and multiple factors should be evaluated.
Advertisement
Advertisement
